 Myelin-Associated Glycoprotein
"Myelin-Associated Glycoprotein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A myelin protein found in the periaxonal membrane of both the central and peripheral nervous systems myelin sheaths. It binds to cells surface receptors found on AXONS and may regulate cellular interactions between MYELIN and AXONS.
| Descriptor ID |
D018992
|
| MeSH Number(s) |
D12.776.395.550.570 D12.776.503.921.049 D12.776.543.550.555 D12.776.543.620.530 D12.776.631.580.500
|
| Concept/Terms |
Myelin-Associated Glycoprotein- Myelin-Associated Glycoprotein
- Myelin Associated Glycoprotein
- Sialic Acid Binding Ig-like Lectin 4
- Sialic Acid Binding Ig like Lectin 4
- Sialic Acid Binding Ig-Like Lectin 4A
- Sialic Acid Binding Ig Like Lectin 4A
- Siglec-4
- Siglec 4
|
Below are MeSH descriptors whose meaning is more general than "Myelin-Associated Glycoprotein".
Below are MeSH descriptors whose meaning is more specific than "Myelin-Associated Glycoprotein".
This graph shows the total number of publications written about "Myelin-Associated Glycoprotein" by people in this website by year, and whether "Myelin-Associated Glycoprotein" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2007 | 1 | 0 | 1 | | 2008 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Myelin-Associated Glycoprotein" by people in Profiles.
-
Kala M, Rhodes SN, Piao WH, Shi FD, Campagnolo DI, Vollmer TL. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp Neurol. 2010 Jan; 221(1):136-45.
-
Sloane E, Ledeboer A, Seibert W, Coats B, van Strien M, Maier SF, Johnson KW, Chavez R, Watkins LR, Leinwand L, Milligan ED, Van Dam AM. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav Immun. 2009 Jan; 23(1):92-100.
-
Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler. 2007 Jan; 13(1):7-16.
-
Yin X, Baek RC, Kirschner DA, Peterson A, Fujii Y, Nave KA, Macklin WB, Trapp BD. Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol. 2006 Jan 30; 172(3):469-78.
-
Fewou SN, B?ssow H, Schaeren-Wiemers N, Vanier MT, Macklin WB, Gieselmann V, Eckhardt M. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase. J Neurochem. 2005 Jul; 94(2):469-81.
-
Calida DM, Constantinescu C, Purev E, Zhang GX, Ventura ES, Lavi E, Rostami A. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice. J Immunol. 2001 Jan 15; 166(2):723-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|